Zhang YZ - Search Results

1

β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer.

Xu C, Jiang ZB, Shao L, Zhao ZM, Fan XX, Sui X, Yu LL, Wang XR, Zhang RN, Wang WJ, Xie YJ, Zhang YZ, Nie XW, Xie C, Huang JM, Wang J, Wang J, Leung EL, Wu QB. Xu C, et al. Among authors: zhang rn, zhang yz. Pharmacol Res. 2023 May;191:106739. doi: 10.1016/j.phrs.2023.106739. Epub 2023 Mar 21. Pharmacol Res. 2023. PMID: 36948327 Free article.

2

MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer.

Duan FG, Wang MF, Cao YB, Dan Li, Li RZ, Fan XX, Khan I, Lai HL, Zhang YZ, Hsiao WW, Yao XJ, Wu QB, Liu L, Tang YJ, Leung EL. Duan FG, et al. Among authors: zhang yz. Cell Death Dis. 2019 Oct 28;10(11):821. doi: 10.1038/s41419-019-2031-1. Cell Death Dis. 2019. PMID: 31659154 Free PMC article.

3

Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancer.

You H, Zhang YZ, Lai HL, Li D, Liu YQ, Li RZ, Khan I, Hsiao WW, Duan FG, Fan XX, Yao XJ, Cao YB, Wu QB, Leung EL, Wang MF. You H, et al. Among authors: zhang yz. J Cancer Res Clin Oncol. 2020 Jun;146(6):1441-1450. doi: 10.1007/s00432-020-03189-8. Epub 2020 Apr 4. J Cancer Res Clin Oncol. 2020. PMID: 32248302

4

Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19: A case report.

Liu Y, Wang M, Luo G, Qian X, Wu C, Zhang Y, Chen B, Leung EL, Tang Y. Liu Y, et al. Medicine (Baltimore). 2020 Oct 16;99(42):e22577. doi: 10.1097/MD.0000000000022577. Medicine (Baltimore). 2020. PMID: 33080692 Free PMC article.

5

Evodiamine suppresses non-small cell lung cancer by elevating CD8⁺ T cells and downregulating the MUC1-C/PD-L1 axis.

Jiang ZB, Huang JM, Xie YJ, Zhang YZ, Chang C, Lai HL, Wang W, Yao XJ, Fan XX, Wu QB, Xie C, Wang MF, Leung EL. Jiang ZB, et al. Among authors: zhang yz. J Exp Clin Cancer Res. 2020 Nov 19;39(1):249. doi: 10.1186/s13046-020-01741-5. J Exp Clin Cancer Res. 2020. PMID: 33208183 Free PMC article.

6

Clinical significance of LSECtin and its association with PVR in non-small-cell lung cancer patients.

Zhang Y, Lai H, Chen P, Li D, Khan I, Hsiao WLW, Fan X, Yao X, Wu Q, Wang M, Leung EL. Zhang Y, et al. Ann Transl Med. 2020 Nov;8(21):1393. doi: 10.21037/atm-20-3665. Ann Transl Med. 2020. PMID: 33313138 Free PMC article.

7

Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8⁺ T cells.

Jiang ZB, Xu C, Wang W, Zhang YZ, Huang JM, Xie YJ, Wang QQ, Fan XX, Yao XJ, Xie C, Wang XR, Yan PY, Ma YP, Wu QB, Leung EL. Jiang ZB, et al. Among authors: zhang yz. Pharmacol Res. 2021 Jul;169:105656. doi: 10.1016/j.phrs.2021.105656. Epub 2021 May 6. Pharmacol Res. 2021. PMID: 33964470

8

Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy.

Huang J, Liu D, Wang Y, Liu L, Li J, Yuan J, Jiang Z, Jiang Z, Hsiao WW, Liu H, Khan I, Xie Y, Wu J, Xie Y, Zhang Y, Fu Y, Liao J, Wang W, Lai H, Shi A, Cai J, Luo L, Li R, Yao X, Fan X, Wu Q, Liu Z, Yan P, Lu J, Yang M, Wang L, Cao Y, Wei H, Leung EL. Huang J, et al. Gut. 2022 Apr;71(4):734-745. doi: 10.1136/gutjnl-2020-321031. Epub 2021 May 18. Gut. 2022. PMID: 34006584 Free PMC article.

9

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.

Jiang ZB, Wang WJ, Xu C, Xie YJ, Wang XR, Zhang YZ, Huang JM, Huang M, Xie C, Liu P, Fan XX, Ma YP, Yan PY, Liu L, Yao XJ, Wu QB, Lai-Han Leung E. Jiang ZB, et al. Among authors: zhang yz. Cancer Lett. 2021 Sep 1;515:36-48. doi: 10.1016/j.canlet.2021.05.019. Epub 2021 May 28. Cancer Lett. 2021. PMID: 34052328

10

Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling.

Li JX, Li RZ, Sun A, Zhou H, Neher E, Yang JS, Huang JM, Zhang YZ, Jiang ZB, Liang TL, Ma LR, Wang J, Wang XR, Fan XQ, Huang J, Xie Y, Liu L, Tang L, Leung EL, Yan PY. Li JX, et al. Among authors: zhang yz. Pharmacol Res. 2021 Sep;171:105574. doi: 10.1016/j.phrs.2021.105574. Epub 2021 Jul 25. Pharmacol Res. 2021. PMID: 34419228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,259 results

Search Page